Items where authors include "Jose, S."

Jump to: Article
Number of items: 29.

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Dark, P., Hossain, A., McAuley, D.F. et al. (543 more authors) (2025) Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. Journal of the American Medical Association (JAMA), 333 (8). pp. 682-693. ISSN 0098-7484

Raman, G. orcid.org/0000-0003-0852-3685, Ronchini, S. orcid.org/0000-0003-0020-687X, Delaunay, J. orcid.org/0000-0001-5229-1995 et al. (1816 more authors) (2025) Swift-BAT GUANO follow-up of gravitational-wave triggers in the third LIGO–Virgo–KAGRA observing run. The Astrophysical Journal, 980 (2). 207. ISSN 0004-637X

Tyrer, F., Gharibzadeh, S., Gillies, C. et al. (1306 more authors) (2025) Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study. Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics, 27 (2). pp. 767-776. ISSN 1462-8902

Gharibzadeh, S., Routen, A., Razieh, C. et al. (1382 more authors) (2025) Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study. eClinicalMedicine, 79. 103005. ISSN 2589-5370

Taquet, M., Skorniewska, Z., De Deyn, T. et al. (1085 more authors) (2024) Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. The Lancet Psychiatry, 11 (9). P696-708. ISSN 2215-0366

Abac, A.G., Abbott, R., Abe, H. et al. (1797 more authors) (2024) Ultralight vector dark matter search using data from the KAGRA O3GK run. Physical Review D, 110 (4). 042001. ISSN 2470-0010

Lawson, C.A., Moss, A.J., Arnold, J.R. et al. (1341 more authors) (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11 (1). e002662. ISSN 2053-3624

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Elneima, O., McAuley, H.J.C., Leavy, O.C. et al. (1398 more authors) (2024) Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Elneima, O. orcid.org/0000-0003-2480-8840, McAuley, H.J.C. orcid.org/0000-0001-8997-0764, Leavy, O.C. et al. (1398 more authors) (2024) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Brightling, C.E., Evans, R.A., Singapuri, A. et al. (1049 more authors) (2023) Long COVID research: an update from the PHOSP-COVID Scientific Summit. The Lancet Respiratory Medicine, 11 (11). e93-e94. ISSN 2213-2600

Raman, B., McCracken, C., Cassar, M.P. et al. (1038 more authors) (2023) Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. The Lancet Respiratory Medicine, 11 (11). pp. 1003-1019. ISSN 2213-2600

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine, 11 (8). pp. 673-684. ISSN 2213-2600

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine. ISSN 2213-2600

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Meng, B., Abdullahi, A., Ferreira, I.A.T.M. et al. (219 more authors) (2022) Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature, 603 (7902). pp. 706-714. ISSN 0028-0836

Mlcochova, P., Kemp, S.A., Dhar, M.S. et al. (258 more authors) (2021) SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature, 599. pp. 114-119. ISSN 0028-0836

This list was generated on Wed Apr 2 07:53:11 2025 BST.